Highlighting the potential of targeting gut epithelial apoptosis, gut-specific overexpression of the anti-apoptotic Bcl-2 in transgenic mice not only reduced sepsis-induced cell death, but it also reduced hyperpermeability and improves survival following intra-abdominal sepsis [57, 58]. Here, BCL2 is linked to Sepsis.